Axelle Vanderlinden onderzoeker

Publicaties Axelle Vanderlinden

From targets to real world impact : a review of models of care for chronic HBV and HCV in Europe

Bron
The Lancet regional health. Europe - ISSN 2666-7762-65 (2026) p.
Auteur(s)
    Camila A. Picchio, Aina Nicolas, Erika Duffell, Elisa Martro, Peter Vickerman, Sandra Dudareva, Sabela Lens, Axelle Vanderlinden, Joaquin Cabezas, Xavier Forns, Upkar S. Gill, Devin Razavi-Shearer, Alessio Aghemo, Rachel Halford, Thomas Vanwolleghem, Philippa C. Matthews

A liver gene signature links liver cancer risk in chronic viral hepatitis to intrahepatic IgA plasma cells

Bron
JHEP Reports - ISSN 2589-5559-8:4 (2026) p. 1-11
Auteur(s)

Clinical trial : hepatitis B virus genotype and a combination of end‐of‐treatment biomarkers predict severe flares after nucleos(t)ide analogue cessation

Bron
Alimentary pharmacology and therapeutics - ISSN 0269-2813-63:3 (2026) p. 352-361
Auteur(s)
    Arno Furquim d'Almeida, Axelle Vanderlinden, Stefan Bourgeois, Jean‐Pierre Mulkay, Thomas Sersté, Mathieu Struyve, Baro Deressa, Dirk Sprengers, Marie de Vos, Jos Callens, Bao Shihao, Hendrik Reynaert, Pierre Deltenre, Filip Janssens, Sergio Negrin‐Dastis, Peter Stärkel, Hans Orlent, Guy Van Roey, Xavier Verhelst, Christophe Moreno, Jean Delwaide, Christophe Van Steenkiste, Wim Verlinden, Isabelle Colle, Marie‐Laure Plissonnier, Benoît Kabamba Mukadi, Barbara Testoni, Fabien Zoulim, Veerle Matheeussen, Thomas Vanwolleghem